Related Experiment Video
Updated: Oct 15, 2025

12:18
Magnetic Resonance Elastography Methodology for the Evaluation of Tissue Engineered Construct Growth
Published on: February 9, 2012
12.6K
Quality control methods in musculoskeletal tissue engineering: from imaging to biosensors
Daniele Zuncheddu1, Elena Della Bella1, Andrea Schwab1
1AO Research Institute Davos, Clavadelerstrasse 8, 7270, Davos, Switzerland.
Bone Research
|October 28, 2021
Summary
This review explores methods for assessing musculoskeletal tissue-engineered constructs. It highlights techniques from classical to novel, emphasizing quality control for clinical application and proposing biosensors for future preimplant monitoring.
Area of Science:
- * Focuses on tissue engineering within the musculoskeletal field.
- * Addresses the growing need for bone and cartilage replacement solutions.
Background:
- * Tissue engineering shows significant promise for clinical applications.
- * Ensuring construct quality is crucial for patient applicability in musculoskeletal regeneration.
Purpose of the Study:
- * To provide an overview of methods for assessing the quality of tissue-engineered musculoskeletal constructs.
- * To classify these methods (destructive, non-invasive, conservative) for preimplant quality monitoring.
- * To highlight the potential of novel technologies like biosensors.
Main Methods:
- * Review of classical techniques: gene expression analysis, histology.
- * Examination of advanced methods: Raman spectroscopy, microcomputed tomography, biosensors.
- * Classification of assessment methods based on invasiveness and impact on construct viability.
Main Results:
- * Various methods exist to evaluate construct viability, morphology, and matrix deposition.
- * Good practices (GXP) are essential for standardization across sectors.
- * Biosensors offer a promising, minimally invasive approach for preimplant quality control.
Conclusions:
- * Rigorous quality assessment is vital for the clinical translation of musculoskeletal tissue engineering.
- * A tiered approach to method selection, considering invasiveness, is recommended.
- * Biosensors represent a novel, advantageous technology for future preimplant quality monitoring systems.

